Evaluation of Transdermal Nicotine Replacement Therapy (NRT) Activity Through Metabolic Induction
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brian Smith, MBBS, PhD
Queen Elizabeth Hospital, University of Adelaide
Principal Investigator - John Beltrame, MBBS, FRACP
Queen Elizabeth Hospital, University of Adelaide
Principal Investigator - Kritin Carson, PhD
Clinical Practice Unit
Principal Investigator - Malcolm Brinn, BHlthSc
Clinical Practice Unit
Principal Investigator - Micahel Ward, PhD
University of South Australia
Principal Investigator - Michael Roberts, BPharm PhD
University of Queeensland, University of South Australia
Principal Investigator - Thomas Robertson, PhD
Therapeutics Research Centre
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kristin Carson
Adelaide, South Australia, Australia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2011
- Primary completion
- 31 Jul 2015
- Completion
- 30 Sept 2015
- Last update posted
- 10 Apr 2017
- Registered enrollment
- 52
- Registry id
- NCT01438944
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.